Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Interventional, Longitudinal APAC Study Evaluating Clinical Utility of GAAD Score for Detection of Hepatocellular Carcinoma in a High-risk APAC Patient Population

NCT07319299 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT07319299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07319299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Interventional, Longitudinal APAC Study Evaluating Clinical Utility of GAAD Score for Detection of Hepatocellular Carcinoma in a High-risk APAC Patient Population
Lead sponsor
Mahidol University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
February 2, 2025
Completion date
December 31, 2027
Enrollment
2,100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hbv infection, hepatecellular carcinoma